Skip to main content

Institutional intelligence for Dr. Reddy's Laboratories Limited

Cross-view mutual fund activity and super-investor shareholding · Jun 2026 SHP.

Ownership breakdown

Category totals from the official quarterly Shareholding Pattern filing (Jun 2026). Sums to 100.00%.

  • Promoters26.64%
  • FII32.07%
  • Mutual Funds13.16%
  • DII (ex-MF)18.58%
  • Retail & others9.55%
  • 1% Club 24.04%(subset)

Super Investors and 1% Club names below are disclosed holders at or above 1%. They are subsets of the categories above, not additive. View filing

Holder details (≥1% disclosed names)

Promoters

Promoter & promoter group

26.64%5 named
HolderStakeSharesValue (₹ Cr)
11.51%9,60,95,920₹12.88k Cr
9.06%7,56,30,620₹10.13k Cr
3.31%2,76,18,385₹3.70k Cr
1.52%1,27,17,090₹1.70k Cr
1.21%1,01,07,505₹1.35k Cr

1% Club — Individuals & others

Non-promoter ≥1% holders not matched to a curated profile

24.04%6 named
HolderStakeSharesValue (₹ Cr)
11.41%0
4.41%3,68,42,838₹4.94k Cr
3.15%2,62,74,811₹3.52k Cr
1.88%1,56,82,948₹2.10k Cr
1.76%1,47,06,891₹1.97k Cr
1.43%1,19,60,032₹1.60k Cr

FII / FPI

Foreign portfolio investors

32.07%1 named
HolderStakeSharesValue (₹ Cr)
1.08%90,38,674₹1.21k Cr

DII (other)

Insurance, banks, AIF, other domestic institutions

18.58%No names

No named holders ≥1% in this bucket.

Mutual Funds

Domestic mutual funds & UTI

13.16%1 named
HolderStakeSharesValue (₹ Cr)
Tracked as LIC12.16%10,15,02,343₹13.60k Cr

Retail & others

Holders below 1% disclosure threshold and public non-institutions

9.55%

SEBI requires naming only shareholders with ≥1% stake. The remaining 9.55% includes retail investors, small HNIs, employee trusts, and other holders below the disclosure threshold — aggregated in the official filing.

Super Investors

Curated tracked investor profiles

No names

No curated super investor holds ≥1% in the latest filing. See FII, DII, and mutual fund holders in the sections above.

Shareholding data sourced from NSE/BSE regulatory filings. Category chart uses official filing totals; named holder lists include every disclosed ≥1% position. Not investment advice. See our disclaimer and methodology.